Risk Factors for Coronary Artery Disease: Historical Perspectives.
作者信息
Hajar Rachel
机构信息
Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
出版信息
Heart Views. 2017 Jul-Sep;18(3):109-114. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17.
Abstract
摘要
相似文献
1
Risk Factors for Coronary Artery Disease: Historical Perspectives.
Heart Views. 2017 Jul-Sep;18(3):109-114. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17.
2
Outcomes for off-pump coronary artery bypass grafting in high-risk groups: a historical perspective.
Heart Surg Forum. 2005;8(1):E19-22. doi: 10.1532/HSF98.20041148.
3
Coronary artery fistulas: clinical and therapeutic considerations.
Int J Cardiol. 2006 Feb 8;107(1):7-10. doi: 10.1016/j.ijcard.2005.01.067. Epub 2005 Aug 24.
4
Operative risk factors in patients with left main coronary-artery disease.
N Engl J Med. 1980 Oct 23;303(17):953-7. doi: 10.1056/NEJM198010233031701.
5
Historical Milestones in the Management of Stable Coronary Artery Disease over the Last Half Century.
Am J Med. 2018 Nov;131(11):1285-1292. doi: 10.1016/j.amjmed.2018.05.039. Epub 2018 Jun 28.
6
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410. doi: 10.1016/j.jcin.2017.08.050.
7
An Update on the Utility of Coronary Artery Calcium Scoring for Coronary Heart Disease and Cardiovascular Disease Risk Prediction.
Curr Atheroscler Rep. 2016 Mar;18(3):13. doi: 10.1007/s11883-016-0565-6.
8
Estrogens and Coronary Artery Disease: New Clinical Perspectives.
Adv Pharmacol. 2016;77:307-60. doi: 10.1016/bs.apha.2016.05.003. Epub 2016 Jun 29.
9
[Historical perspectives on reperfusion therapy in acute myocardial infarction. The 30th anniversary of acute percutaneous coronary intervention].
Dtsch Med Wochenschr. 2008 Oct;133(40):2022-6. doi: 10.1055/s-0028-1085615. Epub 2008 Sep 25.
10
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1116-1123. doi: 10.1016/j.ijrobp.2017.03.026. Epub 2017 Mar 27.
引用本文的文献
1
Sugar-sweetened beverage consumption and risk of premature coronary artery disease in a multi-ethnic Iranian case-control study.
Nutr Metab (Lond). 2025 Aug 27;22(1):102. doi: 10.1186/s12986-025-00999-w.
2
Targeted and safe delivery of colchicine via polymeric nanocarriers for potential atherosclerosis therapy with in vitro and in vivo evaluation.
Sci Rep. 2025 Aug 26;15(1):31334. doi: 10.1038/s41598-025-16131-0.
3
Prakriti elucidates the inter-individual variability in coronary artery disease risk-predicting biomarkers: A tertiary care hospital-based case control study.
J Ayurveda Integr Med. 2025 Aug 18;16(5):101178. doi: 10.1016/j.jaim.2025.101178.
4
Knowledge of risk factors of heart disease among medical students and interns: A cross-sectional study from King Khalid University, Saudi Arabia.
J Family Med Prim Care. 2025 Jun;14(6):2514-2519. doi: 10.4103/jfmpc.jfmpc_744_24. Epub 2025 Jun 30.
5
Screening for Modifiable Risk Factors of Noncommunicable Diseases in Urban Young Adults, Indore, 2023-2024.
Cureus. 2025 Jun 16;17(6):e86179. doi: 10.7759/cureus.86179. eCollection 2025 Jun.
6
Gut microbiota: a novel strategy affecting atherosclerosis.
Microbiol Spectr. 2025 Aug 5;13(8):e0048224. doi: 10.1128/spectrum.00482-24. Epub 2025 Jul 10.
7
Socioenvironmental determinants of nutrition and physical activity among middle-aged individuals at risk of CAD in southern Iran: a qualitative study.
BMJ Open. 2025 Jun 30;15(6):e090314. doi: 10.1136/bmjopen-2024-090314.
8
Analysis and Characterization of Factors Affecting the Consistency of Tl-201 Myocardial Perfusion Single-Photon Emission Computed Tomography and Coronary Angiography Results in Patients with Suspected Coronary Artery Disease.
Diagnostics (Basel). 2025 Jun 18;15(12):1551. doi: 10.3390/diagnostics15121551.
9
Preliminary Evaluation of 3D-Printed Alginate/Gelatin Scaffolds for Protein Fast Release as Suitable Devices for Personalized Medicine.
Biomedicines. 2025 Jun 2;13(6):1365. doi: 10.3390/biomedicines13061365.
10
Assessment of Risk Factors Associated With Coronary Artery Disease in Riyadh, Saudi Arabia: A Cross-Sectional Study.
Cureus. 2025 May 19;17(5):e84441. doi: 10.7759/cureus.84441. eCollection 2025 May.
本文引用的文献
1
Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the Multi-Ethnic Study of Atherosclerosis).
Am J Cardiol. 2014 Oct 15;114(8):1210-4. doi: 10.1016/j.amjcard.2014.07.043. Epub 2014 Jul 30.
2
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
3
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.
Lancet. 2014 Mar 15;383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29.
4
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2010 Dec 21;122(25):e584-636. doi: 10.1161/CIR.0b013e3182051b4c. Epub 2010 Nov 15.
5
Hypertension: reflections on risks and prognostication.
Med Clin North Am. 2009 May;93(3):541-58, Table of Contents. doi: 10.1016/j.mcna.2009.02.006.
6
[Cardiovascular risk factors. Insights from Framingham Heart Study].
Rev Esp Cardiol. 2008 Mar;61(3):299-310.
7
[Childhood obesity. Recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part I. Prevention. Early detection. Role of the pediatrician].
An Pediatr (Barc). 2006 Dec;65(6):607-15. doi: 10.1157/13095854.
8
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Circulation. 2006 Feb 14;113(6):898-918. doi: 10.1161/CIRCULATIONAHA.106.171016. Epub 2005 Dec 27.
9
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
Heart. 2005 Dec;91 Suppl 5(Suppl 5):v1-52. doi: 10.1136/hrt.2005.079988.
10
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Circulation. 2004 Jul 13;110(2):227-39. doi: 10.1161/01.CIR.0000133317.49796.0E.
Zotero 插件